Guardant Health Inc header image

Guardant Health Inc

GH

Equity

ISIN null / Valor 43633454

NASDAQ (2026-11-09)
USD 158.79+5.25%

Guardant Health Inc
UMushroom community rating:

star star star star star
2.92 8 votes No rating yet
NegativeNeutralPositive

About company

Guardant Health Inc is a company that focuses on utilizing blood tests to provide valuable insights for improving clinical outcomes in cancer care. With over 500,000 tests performed by 12,000 doctors, their commercially available tests assist in treatment decisions for advanced cancer patients, monitoring treatment response, detecting residual and recurrent disease in early-stage cancer patients, and potentially screening for cancer before symptoms appear. Additionally, their products support pharmaceutical companies in developing innovative cancer therapies.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

64.2%1Y
606%3Y
47.3%5Y

Performance

56.9%1Y
63.2%3Y
69.0%5Y

Volatility

Market cap

21482 M

Market cap (USD)

Daily traded volume (Shares)

3,142,509

Daily traded volume (Shares)

1 day high/low

31.2 / 29.98

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

2.92

8 votes
Performance:
starstarstarstarstar
3.83
Innovation:
starstarstarstarstar
3.50
Society:
starstarstarstarstar
3.92
Nature:
starstarstarstarstar
3.67
Irfan Hakimi Abd Rashid
UK, 23 Oct 2026
star star star star star
Too risky
Luba Schoenig
Switzerland, 01 Nov 2022
star star star star star
Admin UMushroom
Switzerland, 01 Nov 2022
star star star star star

EQUITIES OF THE SAME SECTOR

Hikma Pharmaceuticals PLC
Hikma Pharmaceuticals PLC Hikma Pharmaceuticals PLC Valor: 2324471
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.52%GBP 16.25
Beximco Pharmaceuticals Ltd
Beximco Pharmaceuticals Ltd Beximco Pharmaceuticals Ltd Valor: 2318407
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.17%GBP 0.63
Pharma Mar SA
Pharma Mar SA Pharma Mar SA Valor: 56130572
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.06%EUR 67.40
Galderma Group Ltd
Galderma Group Ltd Galderma Group Ltd Valor: 133539272
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.57%CHF 190.65
Emeis
Emeis Emeis Valor: 132546338
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.12%EUR 10.85
BioVersys AG
BioVersys AG BioVersys AG Valor: 21036264
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.45%CHF 22.50
Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB Valor: 2676862
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.32%SEK 496.60
Metropolis Healthcare Ltd.
Metropolis Healthcare Ltd. Metropolis Healthcare Ltd. Valor: 11536062
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.20%INR 581.80
Attendo AB
Attendo AB Attendo AB Valor: 30491576
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.61%SEK 127.10
MedCap AB
MedCap AB MedCap AB Valor: 34063678
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.16%SEK 554.50